Drug Approval | May 11, 2022
Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
Subscribe To Our Newsletter & Stay Updated
